Testimony emphasized the need for alternative pain management treatments, and examined how pharmacists can help ensure that patients who use opioids do so safely and effectively.

The new 16-month program provides students with the knowledge and skills necessary to obtain high-level research positions in biopharmaceutical companies and the federal government.

Grant from the U.S. Food and Drug Administration will span three years and include evaluations for more than 200 nominated substances.

Maryland Department of Health awards the Lamy Center a $200,000 contract to help promote appropriate antimicrobial use in long-term care and nursing facilities across the state.

Grant is among the initial group of awards issued by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Biennial event featuring regional experts in computational chemistry highlights recent developments and emerging areas in drug design and development.

$250,000 from Merck will support effort to increase collaboration among patients and health care systems and promote health equity in West Baltimore.

Grant will establish new Center of Excellence at the School to help advance patient-driven solutions in health care.

Dr. Hongbing Wang receives $100,000 from the National Toxicology Program to help support his work to develop a new cell culture model for use in high-throughput screening assays.

The schools of pharmacy, nursing, social work, and law at the University of Maryland, Baltimore are collaborating at a clinic that improves continuity of care for patients discharged from UM Prince George’s Hospital Center.

Time-honored tradition emphasizes the importance of professionalism and celebrates the start of the Class’s journey as student pharmacists.

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.